Welcome to CDC stacks | CDC’s Investments to Combat Antibiotic Resistance Threats Nationwide : Colorado - 50983 | Stephen B. Thacker CDC Library collection
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
CDC’s Investments to Combat Antibiotic Resistance Threats Nationwide : Colorado
Filetype[PDF-558.01 KB]


Details:
  • Description:
    $4,272,480 Funding for AR Activities Fiscal Year 2017

    One of 10 sites for the Emerging Infections Program

    Funding to local health departments:

    $660,783 - RAPID DETECTION & RESPONSE to emerging drug-resistant germs is critical to contain the spread of these infections. With 2016 funding, Colorado increased capacity to respond to emerging threats, including resistant germs, by enhancing lab capacity, coordinating data systems and streamlining outbreak response. When the public health lab detects CRE, the HAI/AR Program provides recommendations to the healthcare facility for preventing transmission.

    $600,001 - HAI/AR PREVENTION works best when public health and healthcare facilities partner together to implement targeted, coordinated strategies to stop infections and improve antibiotic use. With 2016 funding, Colorado engaged local public health agencies, enhanced partnerships and expanded its work with healthcare facilities. The HAI/AR program conducted one-on-one assessments to assist 28 healthcare facilities with infection prevention and/or improving antibiotic use.

    $454,595 - OOD SAFETY projects protect communities by rapidly identifying drug-resistant foodborne bacteria to stop and solve outbreaks and improve prevention. Colorado implemented whole genome sequencing of Listeria, Salmonella, Campylobacter and E. coli isolates submitted to its lab and began uploading sequence data into PulseNet for nationwide monitoring of outbreaks and trends. In Fiscal Year 2018, Colorado will begin simultaneously monitoring these isolates for resistance genes. When outbreaks are detected, local CDC-supported epidemiologists investigate the cases to stop spread.

    $1,131,432 - GONORRHEA RAPID DETECTION & RESPONSE works with state and local epidemiology and laboratory partners to test for and quickly respond to resistant gonorrhea to stop its spread in high risk communities. Only one treatment option remains for gonorrhea and resistance continues to grow. With 2016 funding, Colorado increased their local response capacity and initiating rapid antibiotic susceptibility testing—which determines how well a gonorrhea strain will respond to specific antibiotics. Colorado conducted rapid antibiotic susceptibility testing on 77 gonorrhea specimens in May. Test results are used to inform local outbreak response action, national treatment guidelines and antibiotic resistance trends.

    $1,095,669 - EMERGING INFECTIONS PROGRAM (EIP) sites improve public health by translating population-based surveillance and research activities into informed policy and public health practice. CDC’s EIP network is a national resource for surveillance, prevention and control of emerging infectious diseases—like antibiotic-resistant bacteria and fungi. Learn more: www.cdc.gov/ncezid/dpei/eip.

    Funding to Universities and healthcare partners:

    $330,000 - ASSOCIATION OF OPERATING ROOM NURSES: Discovering & Implementing What Works.Even when cleaned, medical devices can carry germs, including those that are resistant to antibiotics. Investigators will analyze and assess the feasibility of CDC’s National Healthcare Safety Network (NHSN) serving as a national registry for medical devices in order to identify those that may cause infections.

    Publication date from document properties.

    Colorado-2017-CDC-AR-Investments.pdf

  • Place as Subject:
  • Main Document Checksum:
  • Supporting Files:
    No Additional Files
You May Also Like: